Clinical Trial Update: Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis [Phase 1]

View source ↗

Summary

Phase 1 trial comparing two vaginal tablet formulations produced at different sites in postmenopausal women with atrophic vaginitis. Sponsor: Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Vaginal Atrophy

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Menopause, Postmenopausal Vaginal Atrophy | Phase 1 | Status: COMPLETED